Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis
Status:
Not yet recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
This is a prospective,open-labelled,multi-center,randomized clincial trial.It comapres the
clincal efficiacy and safety of there 2 drugs in the treatment of relapse active Takayasu's
arteritis patients.